Form 4: Ardelvx CEO Michael Raab Executes Stock Options and Sells Shares Under 10b5-1 Plan

Michael Raab, President and CEO of Ardelvx, Inc., exercised stock options and sold shares of common stock under a pre-arranged 10b5-1 trading plan.

Summary

• On May 2, 2025, Michael Raab, the President and CEO of Ardelvx, Inc., executed a transaction involving the company's stock.
• Raab exercised stock options to acquire 20,833 shares of common stock at a price of $0.99 per share.
• Simultaneously, Raab sold 41,666 shares of common stock at a weighted average price of $4.2521 per share, with individual trades ranging from $4.10 to $4.54.
• These transactions were conducted under a pre-arranged 10b5-1 trading plan adopted on September 4, 2024.
• Following these transactions, Raab directly owns 1,594,754 shares of Ardelvx common stock.
• Raab also has indirect ownership through a family trust (24,364 shares) and trusts for his children (1,000 shares).
• He also directly owns 415,834 derivative securities (stock options).

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports transactions under a pre-existing trading plan. There's no indication of positive or negative implications for the company's performance.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions. It's common for executives to utilize 10b5-1 trading plans to sell shares over time to avoid accusations of trading on inside information. The market will likely interpret this as a standard part of executive compensation and portfolio management.

Comparison to Industry Standards

• Executive stock option exercises and sales are common across the pharmaceutical industry.
• Companies like Amgen, Gilead Sciences, and Biogen regularly see similar filings from their executives.
• The use of 10b5-1 plans is a standard practice to ensure compliance with insider trading regulations.
• The size of the transaction is relatively small compared to the overall market capitalization of Ardelvx and the holdings of Michael Raab.

Stakeholder Impact

• The stock sale could have a minor impact on shareholders due to the increased supply of shares in the market, but the effect is likely to be minimal given the relatively small size of the transaction.
• The transactions do not directly impact employees, customers, suppliers, or creditors.

Key Dates

Keywords

Ardelvx, Michael Raab, stock options, Form 4, 10b5-1 trading plan, insider trading, ARDX, stock sale, executive compensation